CytomX Therapeutics, Inc. - CTMX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Apr 16, 2026 | SCHEDULE 13G | Point72 Asset Management, L.P. | 5.0% | 10,864,581 | View |
| Apr 16, 2026 | SCHEDULE 13G | Point72 Capital Advisors, Inc. | 5.0% | 10,864,581 | View |
| Apr 16, 2026 | SCHEDULE 13G | Steven A. Cohen | 5.0% | 10,864,581 | View |
| Mar 26, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Mar 04, 2026 | SCHEDULE 13G | Kynam Capital Management, LP | 5.29% | 8,966,077 | View |
| Mar 04, 2026 | SCHEDULE 13G | Kynam Capital Management GP, LLC | 5.29% | 8,966,077 | View |
| Mar 04, 2026 | SCHEDULE 13G | Yue Tang | 5.29% | 8,966,077 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | OrbiMed Advisors LLC | 2.1% | 3,525,650 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL MANAGEMENT, LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | KEVIN TANG | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS, LP | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS INTERNATIONAL, LP | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS III, INC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS IV, INC | 0.0% | 0 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | FMR LLC | 14.6% | 24,688,109 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 14.6% | 24,688,109 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Seven Fleet Master Fund LP | 0.02% | 48,898 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Seven Fleet Capital Management LP | 0.02% | 48,898 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Seven Fleet Capital Management GP LLC | 0.02% | 48,898 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Brian Liu | 0.02% | 48,898 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Point72 Asset Management, L.P. | 2.5% | 4,068,575 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Point72 Capital Advisors, Inc. | 2.5% | 4,068,575 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Steven A. Cohen | 2.5% | 4,068,575 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 9.4% | 15,561,500 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 9.4% | 15,561,500 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 9.4% | 15,561,500 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VHCP Management III, LLC | 9.4% | 15,561,500 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | VHCP Management EG, LLC | 9.4% | 15,561,500 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Nimish Shah | 9.4% | 15,561,500 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Bong Y. Koh | 9.4% | 15,561,500 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | FMR LLC | 12.4% | 20,519,967 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Abigail P. Johnson | 12.4% | 20,519,967 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | FMR LLC | 9.3% | 15,396,200 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | Abigail P. Johnson | 9.3% | 15,396,200 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.